10x Genomics (TXG) Retained Earnings (2018 - 2026)

10x Genomics has disclosed Retained Earnings across 9 years of filings, most recently posting -$1.5 billion for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$1.5 billion, down 1.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 billion (down 1.51% YoY), and the FY2025 annual result was $225000.0, up 145.64% from the prior year.
• Retained Earnings came in at -$1.5 billion for Q1 2026 at 10x Genomics, down from $225000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $225000.0 in Q4 2025 to a low of -$1.5 billion in Q1 2026.
• The 5-year median for Retained Earnings is -$970.2 million (2022), against an average of -$681.7 million.
• Across the five-year window, Retained Earnings plunged 521804.12% in 2022 and jumped 145.64% in 2025, its largest moves.
• 10x Genomics' Retained Earnings stood at -$4.3 million in 2022, then slumped by 29529.07% to -$1.3 billion in 2023, then soared by 99.96% to -$493000.0 in 2024, then surged by 145.64% to $225000.0 in 2025, then sank by 677460.44% to -$1.5 billion in 2026.
• The last three Retained Earnings figures came in at -$1.5 billion (Q1 2026), $225000.0 (Q4 2025), and $138000.0 (Q3 2025), per Business Quant data.